MedTrace Logo

Indoor Daylight Photo Dynamic Therapy for Actinic Keratosis

NCT03805737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2022-01-20

No results posted yet for this study

Summary

The purpose of this study is to understand better if indoor daylight Photo Dynamic Therapy (PDT) can provide effective lesion clearing versus conventional red lamp light therapy.

Conditions

  • Actinic Keratosis

Interventions

OTHER

Amulez and sunlight

Amulez and sun exposure for 2 hours

OTHER

Amulez and red light treatment

Amulez and red light treatment for 10 minutes

Sponsors & Collaborators

  • Norris Cotton Cancer Center

    collaborator OTHER

  • Dartmouth-Hitchcock Medical Center

    lead OTHER

Principal Investigators

  • Michael Shane Chapman, MD · Dartmouth-Hitchcock Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2021-10-06
Completion
2021-10-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805737 on ClinicalTrials.gov